Prescriptions for antidepressant treatment proceed to rise within the UK and globally, partly pushed by growing long-term therapy (Mars et al., 2017). Current knowledge recommend that, in England, round 1 in 15 individuals are actually receiving a prescription for antidepressant treatment (NHSBSA, 2025).
Some people report significant alleviation of their signs from these drugs and enter restoration or change into “remitted” (Eveleigh et al., 2019). At this level, some might really feel prepared to scale back their dose or cease therapy altogether however could also be not sure of the most secure option to go about discontinuing their antidepressants, typically worrying about relapse or withdrawal signs in the event that they try to take action (Eveleigh et al., 2019; Meißner et al., 2024). A double-blind randomised managed trial (ANTLER) performed by Lewis et al. (2021) discovered relapse danger was greater for sufferers who have been discontinuing therapy in contrast with sufferers sustaining their common dose (as summarised in Raphael and Sameer’s Psychological Elf weblog), highlighting potential issues with discontinuation.
Medical pointers supply broad sensible recommendation on the way to handle antidepressant discontinuation. Tapering plans (the place the affected person steadily reduces their dose over time) are often created on a case-by-case foundation between the affected person and their GP, however the optimum velocity and construction of tapering stays unsure (van Leeuwen et al., 2024). Sufferers and clinicians alike would profit from realizing which deprescribing methods minimise relapse danger and the chance of withdrawal results, which is strictly what this systematic assessment and community evaluation by Zaccoletti and colleagues (2025) aimed to do.
People which have recovered following antidepressant therapy typically want to cut back or cease their therapy, however are not sure about one of the simplest ways to do that.
Strategies
Researchers searched medical databases and trial registries as much as April 2025 for randomised managed trials (RCTs) involving adults with depressive or nervousness issues, who have been totally or partially remitted at randomisation and taking an antidepressant. They categorised the discontinuation methods as:
- Abrupt discontinuation
- Quick tapering (gradual antidepressant discontinuation over ≤ 4 weeks) with or with out psychological help
- Gradual tapering (>4 weeks) with or with out psychological help
In addition they included continuation therapy with or with out psychological help. Two researchers independently screened titles, abstracts, and full texts and extracted knowledge utilizing a standardised kind. Outcomes have been analysed utilizing random-effects community meta-analysis, with relapse charge on the finish of the trial as the first endpoint. People with melancholy and nervousness have been analysed collectively after separate analyses confirmed the outcomes have been broadly related. In addition they in contrast the outcomes of various methods throughout totally different courses of antidepressants and confirmed that these results have been additionally constant.
The group additionally assessed danger of bias, heterogeneity, inconsistency, and performed a number of sensitivity analyses. Threat of bias was assessed utilizing the Cochrane Threat-of-Bias instrument 2 and deemed to be low in 53% of research, excessive in 28%, and raised some issues in 20%.
Outcomes
Examine traits
Seventy-six RCTs involving 17,379 members have been included (imply age = 45.9 years; imply proportion feminine = 67.5%). Throughout research, there was a mean follow-up of 46 weeks, with most trials involving people with main depressive dysfunction (79%).
Of the full pattern, 81.7% have been totally remitted and 18.3% partially remitted on the baseline. A lot of the members have been persevering with antidepressant therapy at the usual dose (51%) adopted by abrupt stopping (20%), and quick tapering (19%). Selective Serotonin Reuptake Inhibitors (SSRIs; 40%) and Serotonin Noradrenergic Reuptake Inhibitors (SNRIs; 23%) have been probably the most steadily used antidepressants. Solely 5% acquired psychological help within the type of mindfulness-based cognitive remedy, preventive cognitive remedy, or cognitive behavioural remedy (CBT).
Community meta-analysis
Utilizing abrupt stopping because the reference deprescribing technique, the simplest technique for stopping the danger of relapse was persevering with the antidepressant at normal dose with psychological help (relative danger [RR] = 0.40, 95% confidence interval [CI] [0.26 to 0.61]), adopted by persevering with at normal dose with out help (RR = 0.51, 95% CI [0.46 to 0.58]), and at last gradual tapering with psychological help (RR = 0.52, 95% CI [0.38 to 0.72]). Persevering with at a lowered dose additionally confirmed profit however with decrease certainty (RR = 0.62, 95% CI [0.42 to 0.92]). In distinction, quick tapering with psychological help, abrupt stopping with psychological help, and gradual tapering alone didn’t differ considerably from abrupt discontinuation.
Therapy rankings positioned continuation plus psychological help because the top-performing strategy, intently adopted by gradual tapering plus psychological help. The outcomes seemed to be constant throughout the totally different sensitivity analyses. The RR estimates of every technique have been much less exact after excluding high-risk or industry-sponsored research, however the order of most to least efficient methods remained the identical.
While constant results have been present in subgroup analyses for SSRIs and for depressive issues, the proof for SNRIs, tricyclics, and nervousness issues was much less sure because of the restricted knowledge out there for these drug courses. Another classification of “very gradual tapering” (>12 weeks) was additionally thought of and located this technique was solely efficient when the tapering was mixed with psychological help. No significant variations emerged between discontinuation methods on opposed occasions, severe opposed occasions, or charges of finishing discontinuation. Surprisingly, withdrawal-related results have been barely extra widespread in these persevering with antidepressants than people discontinuing therapy.
Past antidepressant continuation, the simplest technique for stopping danger of relapse in melancholy is gradual tapering together with psychological help.
Conclusions
This community meta-analysis reveals that gradual tapering mixed with psychological help is an efficient and well-tolerated technique for discontinuing antidepressants in remitted people. Its safety in opposition to relapse is akin to persevering with treatment, whereas abrupt stopping and quick tapering considerably enhance relapse danger and ought to be prevented. Psychological help enhances the effectiveness of tapering, whereas help alone doesn’t enhance outcomes when persevering with or abruptly stopping. Though proof for nervousness issues was restricted, general patterns recommend outcomes might generalise cautiously past melancholy.
This assessment underscores the significance of steadily decreasing antidepressant treatment and strongly discourages stopping abruptly or shortly (in 4 weeks or much less).
Strengths and limitations
A serious energy of the research was its complete proof base, synthesising 76 RCTs and greater than 17,000 members; considerably bigger than many earlier meta-analyses on antidepressant discontinuation. This implies the findings relaxation on a giant, well-powered dataset that strengthens the statistical reliability of the conclusions, whereas the inclusion of various research designs and affected person teams additionally makes the outcomes extra strong. Utilizing community meta-analysis allowed the analysis group to check throughout a number of deprescribing methods too, even when trials didn’t instantly examine them, enabling a clearer rating of the totally different medical approaches, which may inform medical decision-making. The authors additionally utilized rigorous methodology, together with duplicate screening and knowledge extraction, formal risk-of-bias evaluation, analysis of transitivity and inconsistency, and intensive sensitivity, subgroup, and meta-regression analyses, which collectively strengthen the reliability of the findings.
Additional, presenting certainty rankings alongside impact sizes permits for a extra dependable interpretation of the effectiveness of every technique that takes into consideration the knowledge of every impact, persevering with to strengthen our belief within the findings. Importantly, incorporating trials with psychological help enabled the first strong, head-to-head comparability of tapering methods with and with out psychotherapy. This issues as a result of it helps establish the deprescribing circumstances underneath which psychological help is probably to scale back relapse danger. Such insights can information clinicians in deciding when and the way to prescribe further remedy throughout discontinuation. Lastly, additionally they consulted a gaggle of people with related lived experiences that knowledgeable the interpretation and dissemination of their analyses. Partaking with members of the general public on the research’s key findings is necessary, to put the ends in context and ideally contribute to the significant implementation of findings. It’s a disgrace that this suggestions was not reported, however this may increasingly have been past the scope of the research’s report.
Nonetheless, some limitations should even be thought of:
- The classification of tapering methods (quick vs gradual taper) was considerably arbitrary and never grounded inside earlier literature or pre-existing medical definitions. Though this distinction might have obscured significant variations in tapering, the authors did check an alternate definition of gradual tapering (‘very gradual tapering’, >12 weeks) in a sensitivity evaluation and located related outcomes.
- The research of sufferers struggling nervousness issues have been underrepresented (~ 20%) and due to this fact solely included proof for fewer methods, limiting generalisability to those issues.
- Proof on the extra help supplied by psychological remedy was additionally comparatively sparse, that means that any conclusions concerning the effectiveness of prescribing psychotherapy alongside a gradual taper, though promising, ought to be thought of preliminary.
Findings point out that psychological help lowers danger of relapse throughout gradual tapering. Nonetheless, restricted proof means it isn’t attainable to attract agency conclusions on their mixed effectiveness.
Implications for apply
These outcomes present worthwhile perception for sufferers excited about stopping antidepressants, in addition to clinicians deciding on the perfect technique to handle antidepressant withdrawal. The primary message is obvious: keep away from abrupt discontinuation or tapering too shortly, as each approaches increase the possibilities of melancholy returning. As a substitute, when contemplating how finest to deprescribe, it appears to be most secure to comply with a gradual tapering plan with further help, which aligns with steerage from the Nationwide Institute for Well being and Care Excellence (NICE, 2022) to:
slowly cut back the dose to zero in a stepwise trend, at every step prescribing a proportion of the earlier dose (for instance, 50% of earlier dose).
The findings of this assessment reinforce the significance of clinicians working with sufferers to create a personalised tapering plan that permits them to steadily cut back their antidepressant dose over time. The outcomes additionally recommend that present medical pointers might go additional by recommending a minimal tapering interval of not less than one month, significantly the place the affected person is apprehensive about relapse or has skilled issue stopping therapy beforehand. The potential added advantages of psychological help when mixed with a gradual tapering regime can also be highlighted, though a lot additional analysis is required disentangle its particular contribution to decreasing relapse danger. Earlier analysis has proven that psychological remedy alongside antidepressant treatment appears to be simpler at treating extreme melancholy than treatment alone (Cuijpers et al., 2023), so psychological remedy throughout withdrawal might supply equally significant advantages.
Future analysis ought to give attention to making detailed comparisons of the effectiveness of various strategies of deprescribing, as a substitute of evaluating upkeep with a single technique of antidepressant discontinuation. Importantly, knowledge on withdrawal signs have been scarce and sometimes poorly measured within the reviewed research, limiting the flexibility to evaluate their function in relapse and the impression of every deprescribing technique on withdrawal-related results (learn Hannah’s Psychological Elf weblog to be taught extra about individuals’s lived experiences of withdrawal signs). This assessment highlights the ongoing gaps in data on withdrawal signs and the necessity for extra longitudinal assessments of discontinuation results while sufferers are steadily decreasing their treatment.
The findings of this assessment align with present NICE pointers relating to the deprescription of antidepressants, but additionally emphasise the significance of clinicians working with sufferers to create tailor-made tapering plans that work finest for them.
Statements of curiosity
None to declare.
Edited by
Dr Nina Higson-Sweeney.
Hyperlinks
Main paper
Zaccoletti, D., Mosconi, C., Gastaldon, C., Benedetti, L., Gottardi, C., Papola, D., Ponzi, O., Purgato, M., Naudet, F., Cristea, I. A., Barbui, C., & Ostuzzi, G. (2025). Comparability of antidepressant deprescribing methods in people with clinically remitted melancholy: a scientific assessment and community meta-analysis. The Lancet Psychiatry, Quantity 13, Difficulty 1, 24 – 36
Different references
Science Media Centre – Professional Response to this paper (Zaccoletti et al, 2025).
Bowers, H. (2024). Antidepressant withdrawal: Suggestions for help from individuals with lived expertise. The Psychological Elf.
Cuijpers, P., Miguel, C., Harrer, M., Plessen, C. Y., Ciharova, M., Papola, D., Ebert, D., & Karyotaki, E. (2023). Psychological therapy of melancholy: A scientific overview of a ‘Meta-Analytic Analysis Area’. Journal of Affective Issues, 335, 141–151. https://doi.org/10.1016/j.jad.2023.05.011
Eveleigh, R., Speckens, A., van Weel, C., Oude Voshaar, R., & Lucassen, P. (2019). Sufferers’ attitudes to discontinuing not-indicated long-term antidepressant use: Limitations and facilitators. Therapeutic Advances in Psychopharmacology, 9, 2045125319872344. https://doi.org/10.1177/2045125319872344
Lewis, G., Marston, L., Duffy, L., Freemantle, N., Gilbody, S., Hunter, R., Kendrick, T., Kessler, D. S., Mangin, D., King, M., Lanham, P., Moore, M., Nazareth, I., Wiles, N. J., Bacon, F., Hen, M., Brabyn, S., Burns, A. J., Clarke, C. S., … Lewis, G. (2021). Upkeep or discontinuation of antidepressants in major care. New England Journal of Drugs, 385(14), 1257-1267. https://doi.org/10.1056/NEJMoa2106356
Mars, B., Heron, J., Kessler, D., Davies, N. M., Martin, R. M., Thomas, Ok. H., & Gunnell, D. (2017). Influences on antidepressant prescribing tendencies within the UK: 1995–2011. Social Psychiatry and Psychiatric Epidemiology, 52(2), 193–200. https://doi.org/10.1007/s00127-016-1306-4
Meißner, C., Warren, C., Fadai, T., Müller, A., Zapf, A., Lezius, S., Ozga, A.-Ok., Falkenberg, I., Kircher, T., & Nestoriuc, Y. (2023). Disentangling pharmacological and expectation results in antidepressant discontinuation amongst sufferers with totally remitted main depressive dysfunction: Examine protocol of a randomized, open-hidden discontinuation trial. BMC Psychiatry, 23(1), 457. https://doi.org/10.1186/s12888-023-04941-3
Nationwide Institute for Well being and Care Excellence. (2022). Melancholy in adults: Therapy and administration (NICE guideline NG222)—Stopping antidepressant treatment. https://www.good.org.uk/steerage/ng222/chapter/suggestions#stopping-antidepressant-medication
NHS Enterprise Companies Authority. (2025, July 24). Medicines utilized in psychological well being – England – 2015/16 to 2024/25. https://www.nhsbsa.nhs.uk/statistical-collections/medicines-used-mental-health-england/medicines-used-mental-health-england-201516-202425
Rifkin-Zybutz, R., & Jauhar, S. (2021). Upkeep or discontinuation of antidepressants for melancholy? Findings from the ANTLER trial. The Psychological Elf.
Van Leeuwen, E., Maund, E., Woods, C., Bowers, H., Christiaens, T., & Kendrick, T. (2024). Well being care skilled boundaries and facilitators to discontinuing antidepressant use: A scientific assessment and thematic synthesis. Journal of Affective Issues, 356, 616–627. https://doi.org/10.1016/j.jad.2024.04.060
Discussion about this post